PCRX  valuation analysis

Basics
Name: Pacira BioSciences, Inc
Description: Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Oct 29, 2020
Market cap: $3.09B (814th)
Sales(TTM): $421.10M (1141st)
Earnings(TTM): $126.12M (642nd)

Value
FFER: 0.87*
Actual price: $71.36
* Earnings were reported Feb 18, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-03-02
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Pacira BioSciences, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Pacira BioSciences, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Pacira BioSciences, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Pacira BioSciences, Inc
"Drug Manufacturers-Specialty & Generic" industry